Is Incyte Corporation overvalued?

Incyte Corporation (INCY) looks undervalued — trading about 33% below its fair value.

Undervalued

Price

$113.75

Fair value

$150.74

Current P/E

17.7

Normal P/E

23.5

Market cap

$22.73B

Dividend yield

0.0%

Return on equity

24.9%

Sector

Healthcare

Fair value compares INCY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks